Latest filing published 11 Jun 2021 for Tricida, Inc..
Filing timeline
BuySaleInsider track record
Klaus R. Dr Veitinger: trading record in brief
Klaus R. Dr Veitinger has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Intercept Pharmaceuticals, Inc., Tricida, Inc. and Relypsa Inc. The record holds 176 filings, for trades running from 9 April 2013 to 10 June 2021.
Sales make up the whole of the open-market record (115 sales, €7.4M). Other entries cover 8 share grants and 53 option exercises.
The latest filing, published on 11 June 2021, reports a share grant in Tricida, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Klaus R. Dr Veitinger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,403 shares0Common StockSEC:0001595585-21-000078:0
- 5,670 shares0Common StockSEC:0001595585-20-000086:0
- 1,750 shares@ US$0.800.0% of flowCommon StockSEC:0001595585-19-000246:0
- 1,750 shares@ US$38.881.5% of flowCommon StockSEC:0001595585-19-000246:1
- 1,750 shares@ US$38.871.5% of flowCommon StockSEC:0001595585-19-000246:3
- 1,750 shares@ US$0.800.0% of flowCommon StockSEC:0001595585-19-000240:0
- 1,750 shares@ US$36.311.4% of flowCommon StockSEC:0001595585-19-000240:1
- 1,750 shares@ US$36.301.4% of flowCommon StockSEC:0001595585-19-000240:2
- 1,750 shares@ US$36.291.4% of flowCommon StockSEC:0001595585-19-000240:3
- 1,400 shares@ US$0.800.0% of flowCommon StockSEC:0001595585-19-000218:0
- 694 shares@ US$30.660.6% of flowCommon StockSEC:0001595585-19-000218:1
- 585 shares@ US$32.050.5% of flowCommon StockSEC:0001595585-19-000218:2
- 121 shares@ US$32.450.1% of flowCommon StockSEC:0001595585-19-000218:3
- 677 shares@ US$30.720.6% of flowCommon StockSEC:0001595585-19-000218:4
- 570 shares@ US$32.010.5% of flowCommon StockSEC:0001595585-19-000218:5
- 153 shares@ US$32.420.1% of flowCommon StockSEC:0001595585-19-000218:6
- 724 shares@ US$30.720.6% of flowCommon StockSEC:0001595585-19-000218:7
- 573 shares@ US$32.120.5% of flowCommon StockSEC:0001595585-19-000218:8
- 103 shares@ US$32.470.1% of flowCommon StockSEC:0001595585-19-000218:9
- 1,400 shares@ US$0.800.0% of flowCommon StockSEC:0001595585-19-000188:0
- 1,400 shares@ US$33.181.3% of flowCommon StockSEC:0001595585-19-000188:1
- 1,400 shares@ US$33.141.3% of flowCommon StockSEC:0001595585-19-000188:2
- 1,400 shares@ US$33.171.3% of flowCommon StockSEC:0001595585-19-000188:3
- 1,400 shares@ US$0.800.0% of flowCommon StockSEC:0001595585-19-000143:0
- 1,400 shares@ US$31.611.2% of flowCommon StockSEC:0001595585-19-000143:1
25 of 173 declarations
